US Stock Movement | Vertex Pharmaceuticals (VRTX.US) surges after hours as late-stage trial of kidney drug povetacicept meets expected targets
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
South Korea KOSPI falls below 7000, turnover hits a new annual low, retail investors and foreign capital record net sales of 33 trillion won in a single month
The rise in U.S. Treasury yields and delays in Oracle data centers are dampening AI investment sentiment. Samsung and SK Hynix shares both fell by over 5% in a single day, with their respective stock buyback programs already 85.95% and 66.27% complete, leaving limited upside potential. Currently, the funds waiting to enter the market in Korean brokerage accounts amount to only 101.63 trillion won. The market is focusing on the U.S. PCE data on September 30 and Micron's financial results.
Ganfeng invests USD 180 million in Lithium Argentina via 6-year convertible note
Centuri names Michael Christy EVP, group development officer
Acuity names Nicholas Tzitzon director
Crypto prices
More
